Skip to content

Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts

A Novel Methadone-induced Memory Retrieval-extinction Procedure to Prevent Heroin Craving and Relapse

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04133974
Enrollment
87
Registered
2019-10-21
Start date
2015-11-20
Completion date
2019-04-20
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Dependence

Brief summary

The study assessed the efficacy of a methadone-induced memory retrieval-extinction procedure on heroin craving and relapse. Male participants aged 18-55 years old and prescribed MMT to treat heroin dependence were included in the present study, and randomly assigned to receive methadone, or receive methadone plus 10 minutes plus extinction, or receive methadone plus 6 hours plus extinction. The intervention persisted 3 times per week for 4 weeks. Then the subjects were followed up once a month for cue induced heroin craving and relapse.

Detailed description

In the present study, we explored the effect retrieval-extinction procedure on heroin craving and relapse in heroin addicts using the methadone (a commonly used µ-opioid receptor agonist) instead of heroin as the trigger to reactivate drug memories. The subjects were randomly divided into 3 groups, in which they received methadone alone or extinction sessions 10 min or 6 hours after methadone administration. The extinction sessions were given 3 times per week for 4 weeks, each lasted for 30 min. During the extinction procedure, the subjects were exposed to images, heroin paraphernalia and mimic heroin. Subjective craving, morphine urine test and physiological responses were recorded monthly for 4 months.

Interventions

BEHAVIORALmethadone induced memory retrieval-extinction procedure

Drug memory is not invariably stable and can be induced transiently labile again by drug-related cues or drug itself, which is termed as 'reconsolidation'. Previously we and other groups have demonstrated that extinction coincided with reconsolidation weakened the drug memory and decreased drug craving and relapse. In the present study, we tried to interfere the methadone-induced heroin addiction memory reconsolidation by extinction given at different times following methadone administration.

Sponsors

National Institute on Drug Dependence, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* met the diagnostic criteria of heroin dependence according to DSM-IV * were prescribed methadone maintenance treatment (MMT) and took it regularly * no change in city of residence for at least 1 year * had normal blood pressure and heart rate * had negative urine morphine screening test * primary-school level education * provide signed consent

Exclusion criteria

* other substance abuse(except nicotine) * had a current or past history of Diagnostic and Statistical Manual of Mental Disorders, 4th Edition(DSM-IV) AxisⅠdisorders * had clinically evident physical disorders * neurological signs and/or history of neurological disease * noncompliance with the procedure

Design outcomes

Primary

MeasureTime frameDescription
change of cue induced heroin cravingBaseline (Day 0 ), post-intervention (1 month), monthly during follow-up for 4 months (2, 3, 4 and 5 month)Heroin craving will be assessed using a visual analog scale (VAS), i.e., an undivided line marked at the left and right ends with 0 (not at all) and 10 (extremely high).
change of negative urinary morphine testBaseline (Day 0), weekly during intervention(1, 2, 3 and 4 week) and monthly during follow-up for 4 months (2, 3, 4 and 5 month)All the participants will be required to have urine tests for morphine during screening, weekly during intervention and monthly during follow-up.

Secondary

MeasureTime frameDescription
cue induced heart rate changeBaseline (Day 0 ), post-intervention (1 month), monthly during follow-up for 4 months (2, 3, 4 and 5 month)Heart rate will be monitored immediately before and after cue exposure
cue induced blood pressure changeBaseline (Day 0 ), post-intervention (1 month), monthly during follow-up for 4 months (2, 3, 4 and 5 month)Blood pressure will be monitored immediately before and after cue exposure.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026